Home Rodeo Therapeutics

Rodeo Therapeutics

acquired
-
Small Molecule Therapy Developer

Basic Information

Rodeo Therapeutics is a drug development company focused on novel enzyme targets and biological pathways that play a key role in tissue repair and regeneration. Rodeo's initial goal is to develop new small-molecule therapies for the treatment of inflammatory bowel disease and to promote blood cell reconstitution after bone marrow transplantation.
Rodeo Therapeutics Corp
Seattle,Washington,United States of America
less than 15 people
January 01, 2017
--
info@rodeotherapeutics.com